Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jan 28;14(1):e233877.
doi: 10.1136/bcr-2019-233877.

Reversible cerebral vasoconstriction syndrome (RCVS) caused by over-the-counter calcium supplement ingestion

Affiliations
Case Reports

Reversible cerebral vasoconstriction syndrome (RCVS) caused by over-the-counter calcium supplement ingestion

Adam Ross Schertz et al. BMJ Case Rep. .

Abstract

A 59-year-old woman was found unresponsive at home. Initial neurologic examination revealed aphasia and right-sided weakness. Laboratory results demonstrated a serum calcium level of 17.3 mg/dL (corrected serum calcium for albumin concentration was 16.8 mg/dL). Extensive workup for intrinsic aetiology of hypercalcemia was unrevealing. Further discussion with family members and investigation of the patient's home for over-the-counter medications and herbal supplements revealed chronic ingestion of calcium carbonate tablets. CT angiogram of the brain revealed multifocal intracranial vascular segmental narrowing, which resolved on a follow-up cerebral angiogram done 2 days later. These findings were consistent with reversible cerebral vasoconstriction syndrome.Appropriate blood pressure control with parenteral agents, calcium channel blockade with nimodipine and supportive care therapies resulted in significant improvement in neurologic status. By discharge, patient had near-complete resolution of neurologic symptoms.

Keywords: adult intensive care; drugs and medicines; drugs: CNS (not psychiatric); neurological injury; stroke.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
MRI brain with hyperintensity (white arrows) seen on diffusion-weighted image (DWI) (A and B), with apparent diffusion coefficient (ADC) maps (C and D) showing corresponding hypointensity (white arrows), indicating acute infarctions of the left occipital cortex, posterior thalamus, hippocampus, anterior temporal cortex, insula and posterior parietal cortex. Corresponding fluid-attenuated inversion recovery (FLAIR) image (E and F) showing expected T2 signal hyperintensity (white arrows) in areas of acute infarction, but absence of vasogenic oedema in white matter regions.
Figure 2
Figure 2
Multifocal irregularities and narrowing of bilateral intracranial arteries (red arrows) (A and B), as seen on CT angiography (CTA) at the base of the brain. Cerebral angiography images acquired 48 hours after CTA showing resolution of the focal narrowing of the same vessels (red arrows) (C and D).

Similar articles

Cited by

References

    1. Singhal AB, Topcuoglu MA, Fok JW, et al. . Reversible cerebral vasoconstriction syndromes and primary angiitis of the central nervous system: clinical, imaging, and angiographic comparison. Ann Neurol 2016;79:882–94. 10.1002/ana.24652 - DOI - PubMed
    1. Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol 2012;11:906–17. 10.1016/S1474-4422(12)70135-7 - DOI - PubMed
    1. Kim JH, Kim MJ, Kang JK, et al. . Vasogenic edema in a case of hypercalcemia-induced posterior reversible encephalopathy. Eur Neurol 2005;53:160–2. 10.1159/000086127 - DOI - PubMed
    1. Chen T-H, Huang C-C, Chang Y-Y, et al. . Vasoconstriction as the etiology of hypercalcemia-induced seizures. Epilepsia 2004;45:551–4. 10.1111/j.0013-9580.2004.57003.x - DOI - PubMed
    1. Chan TLH, Mayich M, Budhram A, et al. . Teaching images in headache: concurrent Hypercalcemia-Induced reversible cerebral vasoconstriction syndrome and posterior reversible encephalopathy syndrome. Headache 2019;59:933–5. 10.1111/head.13528 - DOI - PubMed

Publication types

MeSH terms